TrialJournal of clinical immunology2006

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma.

Joanne H Hasskamp et al.PubMed ↗Publisher ↗

No numbers read from the abstract.